ICU MEDICAL, INC. (NASDAQ:ICUI) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition
ICU Medical, Inc. announced its earnings for the second quarter of 2017.
Item 9.01. Financial Statements and Exhibits.
|
(c) |
Exhibits |
|
99.1 |
Press release, dated August 9, 2017 announcing ICU Medical, Inc.'s second quarter 2017 earnings. |
ICU MEDICAL INC/DE ExhibitEX-99.1 2 exhibit99.htm EXHIBIT 99.1 Q2 2017 ER ANNOUNCEMENT Exhibit Exhibit 99.1ICU Medical,…To view the full exhibit click here
About ICU MEDICAL, INC. (NASDAQ:ICUI)
ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. It operates through the segment, which is engaged in the development, manufacturing and sale of medical technologies used in infusion therapy, critical care and oncology applications. Its Infusion Therapy products include MicroClave and MicroClave Clear, Neutron, NanoClave, Clave and SwabCap. Its Critical Care products include Hemodynamic Monitoring Systems, Closed Blood Sampling and Conservation Systems, and Other Critical Care Products and Accessories. Its Oncology products include ChemoLock CSTD and components, ChemoClave CSTD and components and Diana hazardous drug compounding system.
